SCHEMBL7305557

SCHEMBL7305557

Cc1ccc2c([O])c(C)c(C)cc2c1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 6/20 0.45
LMNA P02545 3/20 0.44
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 2/20 0.42
GAA P10253 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP2A6 P11509 7/20 0.42
TDP1 Q9NUW8 3/20 0.37
CA12 O43570 2/20 0.33
CA9 Q16790 2/20 0.33
LDHA P00338 1/20 0.33
LDHB P07195 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5251220 0.80 CYP1A2 (0.50) CYP1A2LMNAALDH1A1KDM4EGAA
SCHEMBL294408 0.77 CYP1A2 (0.48) CYP1A2ALDH1A1KDM4EGAAHPGD
SCHEMBL12677887 0.75 CYP1A2 (0.45) CYP1A2LMNAALDH1A1KDM4EGAA
SCHEMBL5251216 0.75 CYP1A2 (0.45) CYP1A2LMNAALDH1A1KDM4EGAA
SCHEMBL8376482 0.73 BRD4 (0.40) CYP1A2ALDH1A1KDM4EGAAHPGD
SCHEMBL8743890 0.70 CYP1A2 (0.62) CYP1A2LMNAALDH1A1KDM4EGAA
SCHEMBL11576428 0.69 CYP1A2 (0.52) CYP1A2LMNAALDH1A1KDM4EGAA
SCHEMBL10794827 0.68 CYP1A2 (0.47) CYP1A2LMNAALDH1A1KDM4EGAA
SCHEMBL599080 0.68 CYP1A2 (0.54) CYP1A2LMNAALDH1A1KDM4EGAA
SCHEMBL23322803 0.67 CYP1A2 (0.50) CYP1A2LMNAALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 EP disclosed